GlaxoSmithKline has agreed to pay $3 billion in fines for fraudulently promoting medications for unapproved uses. According to a New York Times report, it’s the largest settlement ever leveled against a pharmaceutical company.
But the settlement doesn’t end the company’s legal disputes. Widespread lawsuits allege that GlaxoSmithKline and other manufacturers of antidepressants classified as selective serotonin reuptake inhibitors failed to adequately warn pregnant patients of studies linking the drugs to continue reading...
U.S. Senator Charles Schumer of New York is calling for a nationwide effort to combat the problem of babies born addicted to prescription painkillers or other opiates, known as Neonatal Abstinence Syndrome (NAS).
Women are more likely than males to take antidepressants, according to the national Centers for Disease Control and Prevention.
In an interview with Metro New York, author Katherine Sharpe discusses some of the reasons behind what she sees as a widespread trend among American medical professionals to overprescribe antidepressants.
According to the National Institute of Mental Health, clinical depression manifests itself in different ways. The types of symptoms – and their severity, frequency and duration – vary depending on the individual and his or her particular illness.
